Crohn’s & Colitis Australia (CCA) provides support programs and advocacy for the health and wellbeing of over 75,000 people afflicted by Inflammatory Bowel Disease (IBD). As part of our mission to improve the lives of those with Crohn’s disease and ulcerative colitis, in 2013 we commissioned PricewaterhouseCoopers Australia (PwC) to update existing IBD national health economic and prevalence data.
The report, Improving Inflammatory Bowel Disease Care across Australia, identified significant geographical variations in access to quality care, and found that the current model of care was inequitable and increasing in cost. It recommended that CCA seek funding to assess existing services in hospitals across Australia.
In 2014 CCA obtained the endorsement of the peak learned bodies representing key health stakeholders to implement the Quality of Care Program. In its first two years the project undertook to develop the Australian IBD Standards and to perform a national audit of the organisation and provision of IBD services in Australia. The intent of the Quality of Care Program is to:
- improve the quality and safety of care for all IBD patients throughout Australia by examining the provision and organisation of IBD care; and
- provide an evidence-based case for allocation of IBD resources that is consistent with national needs, is supported by the key stakeholder groups and aligns with government policy objectives.
The project was funded by the Australian Government Department of Health, CCA, and supported by an educational grants from Janssen (Janssen-Cilag Pty Ltd) and Ferring Pharmaceuticals.
The project was fortunate to be guided by the extensive IBD audit experience in the United Kingdom (UK). Led by the Royal College of Physicians the UK IBD Audit Program implemented four successful rounds of audit over the past 11 years resulting in significant improvements in IBD services.
Enquiries can be directed to email@example.com
Learn more about: